Interventions to improve sleep for individuals with Angelman syndrome: A systematic review.
Study Goal
The researchers aimed to evaluate the effectiveness of interventions, including Melatonin, for improving sleep in individuals with Angelman Syndrome.
Results Summary
The review found mixed outcomes for Melatonin's effectiveness in treating sleep problems in Angelman Syndrome, with pharmacological interventions showing both positive and mixed results. Behavioral interventions, either alone or combined with pharmacological treatments, showed positive outcomes but were based on weak evidence.
Population
Individuals with Angelman Syndrome (54 participants across 10 studies).
Effective Dosage
Not specified
Duration
Not specified
Interactions
None mentioned
| Intervention | Direction | Endpoint | Population | Dosage | Impact | Claim # |
|---|---|---|---|---|---|---|
Pharmacological interventions | decrease | sleep problems | individuals with Angelman Syndrome (AS) | - | demonstrated positive outcomes | #1 |
Pharmacological interventions | no change | sleep problems | individuals with Angelman Syndrome (AS) | - | demonstrated mixed outcomes | #2 |
Behavioral interventions as a sole intervention | decrease | sleep problems | individuals with Angelman Syndrome (AS) | - | were found to have positive outcomes | #3 |
combined pharmacological and behavioral treatment | decrease | sleep problems | individuals with Angelman Syndrome (AS) | - | were found to have positive outcomes | #4 |
behavioral interventions | decrease | sleep problems | individuals with Angelman Syndrome (AS) | - | found provisional evidence but weak evidence for the effectiveness | #5 |
Melatonin | no change | sleep problems | individuals with Angelman Syndrome (AS) | - | mixed outcomes for the effectiveness | #6 |
OBJECTIVE: The aim of the review was to synthesise the literature on the types and effectiveness of interventions to improve sleep for individuals with Angelman Syndrome (AS). METHOD: Four databases were searched using predetermined search terms. Data extraction was performed on studies to examine (a) participant characteristics (b) study design (c) intervention procedures (d) intervention duration (e) dependent (outcome)variables. Intervention outcomes were categorised as positive, negative or and certainty of evidence as a measure of quality was reported for each study. RESULTS: Ten studies, including 54 participants with AS, met the inclusion criteria. Included studies comprised of both single subject designs (n = 3) and group-based designs (n = 7). Pharmacological interventions (n = 8) were the most commonly used followed by combined pharmacological and behavioral treatment (n = 1) or behavioral interventions as a single intervention (n = 1). Pharmacological interventions demonstrated both positive (n = 2) and mixed outcomes (n = 6) and were categorised at a suggestive level of evidence. Behavioral interventions as a sole intervention (n = 1) and as a combined intervention (with pharmacological intervention; n = 1) were found to have positive outcomes and was also categorised at a suggestive level of evidence. CONCLUSION: This review found provisional evidence but weak evidence for the effectiveness of behavioral interventions, and mixed outcomes for the effectiveness of Melatonin for the treatment of sleep problems in AS. All 10 studies only achieved a suggestive level of certainty, therefore, further high-quality research is needed to evaluate interventions for the treatment of sleep problems in this population.